Understand the source comparison
IGF-1 LR3 Real vs Fake: How to Tell — Real Peptides
A 2023 analysis conducted by the Peptide Research Institute found that approximately 40% of IGF-1 LR3 products purchased from unverified online suppliers contained less than 60% of the stated peptide concentration. And 12% contained no detectable IGF-1 LR3 at
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- A 2023 analysis conducted by the Peptide Research Institute found that approximately 40% of IGF-1 LR3 products purchased from unverified online suppliers contained less than 60% of the stated peptide concentration. And 12% contained no detectable IGF-1 LR3 at all. Those aren't just numbers about purity. They represent research cycles wasted, protocols compromised, and in some cases, contamination risks that visual inspection alone cannot identify.
- Our team has vetted peptide batches across hundreds of suppliers in this space. The gap between legitimate research-grade IGF-1 LR3 and convincing counterfeits comes down to three verification methods most researchers never apply until it's too late: reconstitution behavior, solubility consistency, and third-party Certificate of Analysis validation.
- How can you tell if IGF-1 LR3 is real or fake?
- Authentic IGF-1 LR3 displays specific reconstitution characteristics, solubility behavior, and documentation patterns that counterfeits cannot replicate. Legitimate lyophilized IGF-1 LR3 dissolves completely within 60–90 seconds in bacteriostatic water without agitation, leaving no visible particulates or cloudiness. Real peptides arrive with batch-specific Certificates of Analysis showing HPLC purity above 98%, mass spectrometry confirmation of the 83-amino-acid sequence, and endotoxin testing below 1 EU/mg. Counterfeit products typically fail at least one of these three verification points.
- Most researchers assume purity verification requires sending samples to independent labs. And while that's the gold standard, it's not the first line of defense. Visual cues during reconstitution, packaging inconsistencies, and supplier documentation gaps reveal the majority of counterfeits before a single injection occurs. This article covers the physical inspection protocol that catches 70% of fakes within five minutes, the reconstitution tests that identify underdosed or contaminated batches, and the third-party verification process that confirms peptide identity when visual methods aren't enough.